{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:03:58Z","timestamp":1793916238202,"version":"4.8.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T00:00:00Z","timestamp":1326153600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s00702-011-0762-y","type":"journal-article","created":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T07:49:37Z","timestamp":1326095377000},"page":"963-980","source":"Crossref","is-referenced-by-count":23,"title":["Botulinum toxin in hemifacial spasm: the challenge to assess the effect of treatment"],"prefix":"10.1007","volume":"119","author":[{"given":"Bettina","family":"Wabbels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Roggenk\u00e4mper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,10]]},"reference":[{"issue":"11","key":"762_CR1","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/archneur.1990.00530110095023","volume":"47","author":"RG Auger","year":"1990","unstructured":"Auger RG, Whisnant JP (1990) Hemifacial spasm in Rochester and Olmsted Country, Minnesota, 1960\u20131984. Arch Neurol 47(11):1233\u20131234","journal-title":"Arch Neurol"},{"issue":"4","key":"762_CR2","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1590\/S0004-282X2010000400006","volume":"68","author":"ER Barbosa","year":"2010","unstructured":"Barbosa ER, Takada LT, Gon\u00e7alves LR, Costa RM, Silveira-Moriyama L, Chien HF (2010) Botulinum toxin type A in the treatment of hemifacial spasm: an 11-year experience. Arq Neuropsiquiatr 68(4):502\u2013505","journal-title":"Arq Neuropsiquiatr"},{"key":"762_CR3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3171\/jns.1995.82.2.0201","volume":"82","author":"FG Barker","year":"1995","unstructured":"Barker FG, Janetta PJ, Bissonette DJ, Shields PT, Larkins MV, Jho HD (1995) Microvascular decompression for hemifacial spasm. J Neurosurg 82:201\u2013210","journal-title":"J Neurosurg"},{"issue":"3","key":"762_CR4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1468-1331.2008.02507.x","volume":"16","author":"AR Bentivoglio","year":"2009","unstructured":"Bentivoglio AR, Fasano A, Ialongo T, Soleti F, Lo Fermo S, Albanese A (2009) Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm. Eur J Neurol 16(3):392\u2013398","journal-title":"Eur J Neurol"},{"issue":"5","key":"762_CR5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF02340723","volume":"14","author":"A Berardelli","year":"1993","unstructured":"Berardelli A, Formica A, Mercuri B, Abbruzzese G, Agnoli A, Agostino R, Caraceni T, Carella F, De Fazio G, De Grandis D et al (1993) Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group. Ital J Neurol Sci 14(5):361\u2013367","journal-title":"Ital J Neurol Sci"},{"key":"762_CR6","first-page":"1607","volume":"31","author":"D Bremond-Gignac","year":"2002","unstructured":"Bremond-Gignac D, Tixier J, Missotten T, Laroche L, Beresniak A (2002) Evaluation of the quality of life in ophthalmology. Presse Med 31:1607\u20131612","journal-title":"Presse Med"},{"key":"762_CR7","first-page":"183","volume-title":"Treatment of movement disorders","author":"MF Brin","year":"1995","unstructured":"Brin MF, Jancovic J, Comella C, Blitzer A, Tsui JKC, Pullman SL (1995) Treatment of dystonia using botulinum toxin. In: Kurlan R (ed) Treatment of movement disorders. Lippincott Company, New York, pp 183\u2013246"},{"issue":"1","key":"762_CR8","first-page":"1","volume":"62","author":"LB Chang","year":"1999","unstructured":"Chang LB, Tsai CP, Liao KK, Kao KP, Yuan CL, Yen DJ, Lin KP (1999) Use of botulinum toxin A in the treatment of hemifacial spasm and blepharospasm. Zhonghua Yi Xue Za Zhi (Taipei) 62(1):1\u20135","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"issue":"3","key":"762_CR9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-0404.1996.tb07053.x","volume":"94","author":"RS Chen","year":"1996","unstructured":"Chen RS, Lu CS, Tsai CH (1996) Botulinum toxin A injection in the treatment of hemifacial spasm. Acta Neurol Scand 94(3):207\u2013211","journal-title":"Acta Neurol Scand"},{"issue":"8","key":"762_CR10","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s11136-010-9673-x","volume":"19","author":"D Cherepanov","year":"2010","unstructured":"Cherepanov D, Palta M, Fryback DG, Robert AS (2010) Gender differences in health-related quality-of-life are partly explained by sociodemographic and socioeconomic variation between adult men and women in the US: evidence from four US nationally representative data sets. Qual Life Res 19(8):1115\u20131124","journal-title":"Qual Life Res"},{"key":"762_CR11","doi-asserted-by":"crossref","unstructured":"Costa J, Espirito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C (2005) Botulinum toxin type A therapy for hemifacial spasm. Cochrane Database Syst Rev 1:CD004899","DOI":"10.1002\/14651858.CD004899.pub2"},{"issue":"3","key":"762_CR12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF02333858","volume":"11","author":"G Defazio","year":"1990","unstructured":"Defazio G, Lepore V, Lamberti P, Livrea P, Ferrari E (1990) Botulinum A toxin treatment for eyelid spasm, spasmodic torticollis and apraxia of eyelid opening. Ital J Neurol Sci 11(3):275\u2013280","journal-title":"Ital J Neurol Sci"},{"issue":"3","key":"762_CR01","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1001\/archneur.59.3.418","volume":"59","author":"G Defazio","year":"2002","unstructured":"Defazio G, Abbruzzese G, Girlanda P, Vacca L, Curr\u00e0 A, De Salvia R, Marchese R, Raineri R, Roselli F, Livrea P, Berardelli A (2002) Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study. Arch Neurol 59(3):418\u2013420","journal-title":"Arch Neurol"},{"key":"762_CR13","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/jnnp.49.7.827","volume":"49","author":"JS Elston","year":"1986","unstructured":"Elston JS (1986) Botulinum toxin treatment of hemifacial spasm. J Neurol Neurosurg Psychiatry 49:827\u2013829","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"762_CR14","first-page":"285","volume":"84","author":"JS Elston","year":"1990","unstructured":"Elston JS (1990) Botulinum toxin A in clinical medicine. J Physiol (Paris) 84(4):285\u2013289","journal-title":"J Physiol (Paris)"},{"issue":"1","key":"762_CR15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00839203","volume":"239","author":"JS Elston","year":"1992","unstructured":"Elston JS (1992) The management of blepharospasm and hemifacial spasm. J Neurol 239(1):5\u20138","journal-title":"J Neurol"},{"key":"762_CR16","unstructured":"Fahn (1985) Rating scales for blepharospasm. In: Bosniak SL (ed) Blepharospasm, advanced ophthalmology plastic reconstructive surgery. Pergamon Press, New York, pp 97\u2013101"},{"issue":"Suppl 1","key":"762_CR17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1468-1331.2006.01442.x","volume":"13","author":"K Frei","year":"2006","unstructured":"Frei K, Truong DD, Dressler D (2006) Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations. Eur J Neurol 13(Suppl 1):30\u201335","journal-title":"Eur J Neurol"},{"key":"762_CR18","first-page":"S77","volume":"113","author":"S Goertelmeyer","year":"2002","unstructured":"Goertelmeyer S, Brinkmann G, Comes A, Delcker A (2002) The Blepharospasm Disability Index (BSDI) for the assessment of functional health in focal dystonia. Clin Neurophysiol 113:S77\u2013S78","journal-title":"Clin Neurophysiol"},{"key":"762_CR19","first-page":"447","volume":"51","author":"M Gupta","year":"2003","unstructured":"Gupta M, Singh G, Khwaja G (2003) Botulinum toxin in the treatment of dystonias\u2014a hospital based study. J Assoc Physicians India 51:447\u2013453","journal-title":"J Assoc Physicians India"},{"issue":"6","key":"762_CR20","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/mds.10252","volume":"17","author":"GY Hsiung","year":"2002","unstructured":"Hsiung GY, Das SK, Ranawaya R, Lafontaine AL, Suchowersky O (2002) Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period. Mov Disord 17(6):1288\u20131293","journal-title":"Mov Disord"},{"key":"762_CR21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1477-7525-7-104","volume":"7","author":"YC Huang","year":"2009","unstructured":"Huang YC, Fan JY, Ro LS, Lyu RK, Chang HS, Chen ST, Hsu WC, Chen CM, Wu YR (2009) Validation of a Chinese version of disease specific quality of life scale (HFS-36) for hemifacial spasm in Taiwan. Health Qual Life Outcomes 7:104","journal-title":"Health Qual Life Outcomes"},{"key":"762_CR22","first-page":"153","volume":"10","author":"AB Jamjoon","year":"1990","unstructured":"Jamjoon AB, Anderson RL, Jordan DR, Patrinely JR (1990) Bilateral hemifacial spasm. J Clin Neuro Ophtalmol 10:153\u2013154","journal-title":"J Clin Neuro Ophtalmol"},{"key":"762_CR23","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1212\/WNL.37.4.616","volume":"37","author":"J Jankovic","year":"1987","unstructured":"Jankovic J, Orman J (1987) Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study. Neurology 37:616\u2013623","journal-title":"Neurology"},{"issue":"6","key":"762_CR24","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/jnnp.64.6.751","volume":"64","author":"S Jitpimolmard","year":"1998","unstructured":"Jitpimolmard S, Tiamkao S, Laopaiboon M (1998) Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases. J Neurol Neurosurg Psychiatry 64(6):751\u2013757","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl. 1","key":"762_CR25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/PL00007813","volume":"248","author":"W Jost","year":"2001","unstructured":"Jost W, Kohl A (2001) Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm. J Neurol 248(Suppl. 1):21\u201324","journal-title":"J Neurol"},{"key":"762_CR26","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00702-007-0768-7","volume":"115","author":"C Kenney","year":"2008","unstructured":"Kenney C, Jankovic J (2008) Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neural Transm 115:585\u2013591","journal-title":"J Neural Transm"},{"issue":"6","key":"762_CR27","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00702-010-0409-4","volume":"117","author":"K Kollewe","year":"2010","unstructured":"Kollewe K, Mohammadi B, Dengler R, Dressler D (2010) Hemifacial spasm and reinnervation synkinesias: long-term treatment with either Botox or Dysport. J Neural Transm 117(6):759\u2013763","journal-title":"J Neural Transm"},{"issue":"3","key":"762_CR28","first-page":"279","volume":"4","author":"MC Kwan","year":"1998","unstructured":"Kwan MC, Ko KF, Chan TP, Chan YW (1998) Treatment of dystonia with botulinum A toxin: a retrospective study of 170 patients. Hong Kong Med J 4(3):279\u2013282","journal-title":"Hong Kong Med J"},{"issue":"2","key":"762_CR29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2125.1981.tb01118.x","volume":"11","author":"CD Marsden","year":"1981","unstructured":"Marsden CD, Schachter M (1981) Assessment of extrapyramidal disorders. Br J Clin Pharmacol 11(2):129\u2013151","journal-title":"Br J Clin Pharmacol"},{"key":"762_CR30","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/archneur.57.8.1224","volume":"57","author":"AR Meyers","year":"2000","unstructured":"Meyers AR, Gage H, Hendricks A (2000) Health-related quality of life in neurology. Arch Neurol 57:1224\u20131227","journal-title":"Arch Neurol"},{"key":"762_CR31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0090-3019(92)90170-R","volume":"38","author":"S Nagata","year":"1992","unstructured":"Nagata S, Matsushima T, Fujii K, Masashi F, Kuromatsu C (1992) Hemifacial spasm due to tumor, aneurysm, or arteriovenous malformation. Surg Neurol 38:204\u2013209","journal-title":"Surg Neurol"},{"issue":"5","key":"762_CR32","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3346\/jkms.1993.8.5.334","volume":"8","author":"YC Park","year":"1993","unstructured":"Park YC, Lim JK, Lee DK, Yi SD (1993) Botulinum a toxin treatment of hemifacial spasm and blepharospasm. J Korean Med Sci 8(5):334\u2013340","journal-title":"J Korean Med Sci"},{"key":"762_CR33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF02260863","volume":"4","author":"V Peto","year":"1995","unstructured":"Peto V, Jenkinson C, Fitzpatrick R, Greenhall R (1995) The development and validation of a of a short measure of functioning and well being for individuals with Parkinson\u2019s disease. Qual Life Res 4:241\u2013248","journal-title":"Qual Life Res"},{"issue":"6","key":"762_CR34","first-page":"281","volume":"78","author":"N Poungvarin","year":"1995","unstructured":"Poungvarin N, Devahastin V, Viriyavejakul A (1995a) Treatment of various movement disorders with botulinum A toxin injection: an experience of 900 patients. J Med Assoc Thail 78(6):281\u2013288","journal-title":"J Med Assoc Thail"},{"issue":"2","key":"762_CR35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/1353-8020(95)00003-8","volume":"1","author":"N Poungvarin","year":"1995","unstructured":"Poungvarin N, Viriyavejakul A, Komoltri C (1995b) Placebo-controlled double-blind cross-over study of botulinum A toxin in hemifacial spasm. Parkinsonism Relat Disord 1(2):85\u201388","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"762_CR36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1442-9071.1994.tb00793.x","volume":"22","author":"J Price","year":"1994","unstructured":"Price J, O\u2019Day J (1994) Efficacy and side effects of botulinum toxin treatment for blephrospasm and hemifacial spasm. Aust N Z J Ophthalmol 22(4):255\u2013260","journal-title":"Aust N Z J Ophthalmol"},{"issue":"1","key":"762_CR37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/WNF.0b013e3181c46f61","volume":"33","author":"EM Quagliato","year":"2010","unstructured":"Quagliato EM, Carelli EF, Viana MA (2010) Prospective, randomized, double-blind study, comparing botulinum toxins type a botox and prosigne for blepharospasm and hemifacial spasm treatment. Clin Neuropharmacol 33(1):27\u201331","journal-title":"Clin Neuropharmacol"},{"key":"762_CR38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1159\/000319883","volume":"88","author":"DK Ray","year":"2010","unstructured":"Ray DK, Bahgat D, Mc Cartney S, Burchiel KJ (2010) Surgical outcome and improvement in quality of life after microvascular decompression for hemifacial spasms: a case series asessessment using a validated disease-specific scale. Stereotact Funct Neurosurg 88:383\u2013389","journal-title":"Stereotact Funct Neurosurg"},{"key":"762_CR39","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1600-0404.2004.00357.x","volume":"111","author":"J Reimer","year":"2005","unstructured":"Reimer J, Gilg K, Karow A, Esser J, Franke GH (2005) Health-related quality of life in blepharospasm or hemifacial spasm. Acta Neurol Scand 111:64\u201370","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"762_CR40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.WNF.0000236771.77021.3C","volume":"30","author":"CR Rieder","year":"2007","unstructured":"Rieder CR, Schestatsky P, Socal MP, Monte TL, Fricke D, Costa J, Picon PD (2007) A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasm. Clin Neuropharmacol 30(1):39\u201342","journal-title":"Clin Neuropharmacol"},{"key":"762_CR41","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00702-005-0323-3","volume":"113","author":"P Roggenk\u00e4mper","year":"2006","unstructured":"Roggenk\u00e4mper P, Jost WH, Bihari K, Comes G, Grafe S (2006) Efficacy and safety of a new botulinum toxin type A free of complexing proteins in the treatment of blepharospasm. J Neural Transm 113:303\u2013312","journal-title":"J Neural Transm"},{"issue":"6","key":"762_CR42","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00702-010-0416-5","volume":"117","author":"M Rudzi\u0144ska","year":"2010","unstructured":"Rudzi\u0144ska M, W\u00f3jcik M, Szczudlik A (2010) Hemifacial spasm non-motor and motor-related symptoms and their response to botulinum toxin therapy. J Neural Transm 117(6):765\u2013772","journal-title":"J Neural Transm"},{"issue":"6","key":"762_CR43","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/mds.870120627","volume":"12","author":"C Sampaio","year":"1997","unstructured":"Sampaio C, Ferreira JJ, Sim\u00f5es F, Rosas MJ, Magalh\u00e3es M, Correia AP, Bastos-Lima A, Martins R, Castro-Caldas A (1997) DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A\u2014Dysport and Botox\u2014assuming a ratio of 4:1. Mov Disord 12(6):1013\u20131018","journal-title":"Mov Disord"},{"key":"762_CR44","first-page":"59","volume":"111","author":"P Schnider","year":"1999","unstructured":"Schnider P, Birner P, Morard E, Au E (1999) Long-term treatment with botulinum toxin: dosage treatment schedules and costs. Wien Klin Wochenschr 111:59\u201365","journal-title":"Wien Klin Wochenschr"},{"key":"762_CR45","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/01.wnl.0000311389.26145.95","volume":"70","author":"DM Simpson","year":"2008","unstructured":"Simpson DM, Blitzer A, Brashear A, Comella C, Dubinsky R, Hallet M, Jankovic J, Karp B, Ludlow CL, Miyasaki JM, Naumann M, So Y (2008) Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 70:1699\u20131706","journal-title":"Neurology"},{"issue":"10","key":"762_CR46","first-page":"1205","volume":"87","author":"A Suputtitada","year":"2004","unstructured":"Suputtitada A, Phanthumchinda K, Locharernkul C, Suwanwela NC (2004) Hemifacial spasm: results of treatment with low dose botulinum toxin injection. J Med Assoc Thail 87(10):1205\u20131211","journal-title":"J Med Assoc Thail"},{"issue":"8","key":"762_CR47","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/archopht.125.8.1141-a","volume":"125","author":"EK Tan","year":"2007","unstructured":"Tan EK, Seah A (2007) Health-related quality of life in blepharospasm and hemifacial spasm. Arch Ophthalmol 125(8):1141","journal-title":"Arch Ophthalmol"},{"key":"762_CR48","first-page":"169","volume":"28","author":"EK Tan","year":"1999","unstructured":"Tan EK, Chan LL, Lim SH, Lim WE, Khoo JB, Tun KP (1999) Role of magnetic resonance imaging and magnetic resonance angiography in patients with hemifacial spasm. Ann Acad Med Singap 28:169\u2013173","journal-title":"Ann Acad Med Singap"},{"issue":"1\u20132","key":"762_CR49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jns.2004.01.010","volume":"219","author":"EK Tan","year":"2004","unstructured":"Tan EK, Fook-Chong S, Lum SY, Lim E (2004) Botulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30). J Neurol Sci 219(1\u20132):151\u2013155","journal-title":"J Neurol Sci"},{"key":"762_CR50","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1136\/jnnp.2005.065656","volume":"76","author":"EK Tan","year":"2005","unstructured":"Tan EK, Fook-Chong S, Lum S-Y, Thumboo J (2005) Validation of a disease specific quality of life scale for hemifacial spasm: correlation with SF-36. J Neurol Neurosurg Psychiatry 76:1707\u20131710","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"762_CR51","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.clineuro.2008.05.010","volume":"110","author":"EK Tan","year":"2008","unstructured":"Tan EK, Hameed S, Fook-Chong S, Hussein K, Lum SY, Chan LL (2008) Treatment outcome correlates with knowledge of disease in hemifacial spasm. Clin Neurol Neurosurg 110(8):813\u2013817","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"762_CR52","first-page":"133","volume":"26","author":"JD Taylor","year":"1991","unstructured":"Taylor JD, Kraft SP, Kazdan MS, Flanders M, Cadera W, Orton RB (1991) Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: a Canadian multicentre study. Can J Ophthalmol 26(3):133\u2013138","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"762_CR53","first-page":"61","volume":"14","author":"CP Tsai","year":"2005","unstructured":"Tsai CP, Chiu MC, Yen DJ, Guo YC, Yuan CL, Lee TC (2005) Quantitative assessment of efficacy of Dysport (botulinum toxin type A) in the treatment of idiopathic blepharospasm and hemifacial spasm. Acta Neurol Taiwan 14(2):61\u201368","journal-title":"Acta Neurol Taiwan"},{"issue":"3","key":"762_CR54","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jocn.2007.02.002","volume":"15","author":"T Tun\u00e7","year":"2008","unstructured":"Tun\u00e7 T, Cavdar L, Karada\u011f YS, Okuyucu E, Co\u015fkun O, Inan LE (2008) Pain relief in patients receiving periocular botulinum toxin A. J Clin Neurosci 15(3):253\u2013256","journal-title":"J Clin Neurosci"},{"issue":"7","key":"762_CR55","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/mus.880180708","volume":"18","author":"P Bergh Van den","year":"1995","unstructured":"Van den Bergh P, Francart J, Mourin S, Kollmann P, Laterre EC (1995) Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin. Muscle Nerve 18(7):720\u2013729","journal-title":"Muscle Nerve"},{"issue":"6","key":"762_CR56","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00702-010-0546-9","volume":"118","author":"B Wabbels","year":"2011","unstructured":"Wabbels B, Jost WH, Roggenk\u00e4mper P (2011) Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm. J Neural Transm 118(6):925\u2013943","journal-title":"J Neural Transm"},{"key":"762_CR57","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/(SICI)1097-4598(199812)21:12<1740::AID-MUS17>3.0.CO;2-V","volume":"21","author":"A Wang","year":"1998","unstructured":"Wang A, Jancovic J (1998) Hemifacial spasm: clinical findings and treatment. Muscle Nerve 21:1740\u20131747","journal-title":"Muscle Nerve"},{"key":"762_CR58","unstructured":"Ware JE, Snow KK, Kosinski M, Gandek B (1993) SF-36 Health-Survey manual and interpretation guide. Nimrod Press, Boston"},{"issue":"9","key":"762_CR59","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/mus.880150909","volume":"15","author":"DM Yoshimura","year":"1992","unstructured":"Yoshimura DM, Aminoff MJ, Tami TA, Scott AB (1992) Treatment of hemifacial spasm with botulinum toxin. Muscle Nerve 15(9):1045\u20131049","journal-title":"Muscle Nerve"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-011-0762-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-011-0762-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-011-0762-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,25]],"date-time":"2021-12-25T08:48:07Z","timestamp":1640422087000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-011-0762-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,10]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["762"],"URL":"https:\/\/doi.org\/10.1007\/s00702-011-0762-y","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,10]]}}}